scispace - formally typeset
Journal ArticleDOI

Advances in targeting the WNT/β-catenin signaling pathway in cancer.

TLDR
In this article, the authors discuss the pathway, potential targets for the development of WNT/β-catenin inhibitors, available inhibitors, and their specific molecular interactions with the target proteins.
About
This article is published in Drug Discovery Today.The article was published on 2021-07-10. It has received 28 citations till now. The article focuses on the topics: Wnt signaling pathway & Wnt signaling pathway.

read more

Citations
More filters
Journal ArticleDOI

Wnt/beta-catenin signaling confers ferroptosis resistance by targeting GPX4 in gastric cancer

TL;DR: In this paper , the Wnt/beta-catenin signaling attenuates cellular lipid ROS production and subsequently inhibits ferroptosis in GC cells, which is a form of regulated cell death induced by an iron-dependent accumulation of lipid peroxides during chemotherapy.
Journal ArticleDOI

miRNAs as potential game-changers in bone diseases: Future medicinal and clinical uses.

TL;DR: In this article , the most up-to-date information on the clinical relevance of micro-RNAs in bone disorders was brought together to explore their potential as a therapeutic target.
Journal ArticleDOI

Targeting Wnt/β-Catenin Pathways in Primary Liver Tumours: From Microenvironment Signaling to Therapeutic Agents

TL;DR: The dysregulation of the Wnt/β-catenin signaling network is discussed, especially in hepatocellular carcinoma, in cholangiocarcinoma and in patients with hepatoblastoma, and the clinical implication of Wnt inhibitors in association with conventional surgical and lo-co-regional therapies is reviewed.
Journal ArticleDOI

Inhibition of Wnt/β-Catenin Signaling Sensitizes Esophageal Cancer Cells to Chemoradiotherapy.

TL;DR: Wang et al. as mentioned in this paper investigated the impact of Wnt/β-catenin signaling on preoperative chemoradiotherapy (CRT) resistance in esophageal cancer cells.
Journal ArticleDOI

Update on Biology and Genomics of Adrenocortical Carcinomas: Rationale for Emerging Therapies.

TL;DR: A comprehensive, integrated and current bench-to-bedside understanding of the field's investigations into adrenocortical physiology and neoplasia is crucial to developing novel clinical tools and approaches to equip the one-in-a-million patient fighting this devastating disease.
References
More filters
Journal ArticleDOI

Cell signaling by receptor-tyrosine kinases

TL;DR: Understanding of the complex signaling networks downstream from RTKs and how alterations in these networks are translated into cellular responses provides an important context for therapeutically countering the effects of pathogenic RTK mutations in cancer and other diseases.
Journal ArticleDOI

Improved protein structure prediction using potentials from deep learning

TL;DR: It is shown that a neural network can be trained to make accurate predictions of the distances between pairs of residues, which convey more information about the structure than contact predictions, and the resulting potential can be optimized by a simple gradient descent algorithm to generate structures without complex sampling procedures.
Journal ArticleDOI

Oncogenic Signaling Pathways in The Cancer Genome Atlas

TL;DR: This work charted the detailed landscape of pathway alterations in 33 cancer types, stratified into 64 subtypes, and identified patterns of co-occurrence and mutual exclusivity.
Journal ArticleDOI

Pan-cancer analysis of whole genomes

Peter J. Campbell, +1332 more
- 06 Feb 2020 - 
TL;DR: The flagship paper of the ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium describes the generation of the integrative analyses of 2,658 whole-cancer genomes and their matching normal tissues across 38 tumour types, the structures for international data sharing and standardized analyses, and the main scientific findings from across the consortium studies.
Related Papers (5)
Trending Questions (2)
Is ERB2 and ERB5 expression associated with WNT/β-catenin signaling in human breast cancer?

The answer to the query is not provided in the paper. The paper discusses the WNT/β-catenin signaling pathway, potential targets for inhibitors, available inhibitors, and strategies for targeting the pathway in cancer therapy. It does not mention ERB2 or ERB5 expression in relation to WNT/β-catenin signaling in human breast cancer.

Cancer cell specific inhibition of WNT/Beta-catenin signaling by forced intracellular

The paper discusses potential targets and inhibitors for inhibiting the WNT/β-catenin signaling pathway in cancer cells.